Sponsor
Syntara
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Syntara appears in 16 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
16 shownA Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe AsthmaNCT01380236 · lead sponsor · 2011-11-01
WITHDRAWNEfficacy of TPI ASM8 During a 14-Day Allergen ChallengeNCT01158898 · lead sponsor · 2010-11-01
COMPLETEDEfficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic AsthmaNCT00822861 · lead sponsor · 2009-04-01
COMPLETEDSafety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy VolunteersNCT00914433 · lead sponsor · 2009-04-01
WITHDRAWNStudy to Evaluate the Safety and Efficacy TPI ASM8 in Subjects With AsthmaNCT00550797 · lead sponsor · 2008-01-01
COMPLETEDInspiratory Flow Using the OsmohalerNCT00531414 · lead sponsor · 2007-11-01
COMPLETEDSafety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD PatientsNCT00483743 · lead sponsor · 2007-11-01
COMPLETEDSafety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic PatientsNCT00402948 · lead sponsor · 2007-02-01
TERMINATEDA Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPDNCT00446667 · lead sponsor · 2006-10-01
WITHDRAWNInhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible AsthmaNCT00327808 · lead sponsor · 2006-05-01
COMPLETEDMultiple Dose ASM8 in Mild AsthmaticsNCT00264966 · lead sponsor · 2005-12-01
COMPLETEDAbility of Aridol to Detect Bronchial Hyperresponsiveness in Suspected AsthmaticsNCT00252291 · lead sponsor · 2005-11-01
COMPLETEDAridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPDNCT00117182 · lead sponsor · 2005-07-01
COMPLETEDMannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic AsthmaNCT03620422 · collaborator · 2019-01-11
COMPLETEDThe Leaky Lung TestNCT02306473 · collaborator · 2015-10-01
COMPLETEDMannitol Bronchoprovocation Challenge Ancillary Study/ACRNNCT00585260 · collaborator · 2007-12-01
COMPLETEDSponsor roles
lead sponsor13
collaborator3
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.